Ascites in Hepatic Cirrhosis
Adil Abbasi, MD FACP
Learning Objectives
After completing this chapter, the reader should be able to:
Introduction: Ascites refers to the pathological accumulation of fluid within the peritoneal cavity. It is the most common complication of decompensated liver cirrhosis and represents a major turning point in the natural history of chronic liver disease. Approximately 50% of patients with compensated cirrhosis develop ascites within 10 years of diagnosis.
The development of ascites indicates significant portal hypertension and impaired hepatic function. Once ascites develop, mortality increases substantially, with an estimated 50% two-year survival rate if liver transplantation is not performed.
Although cirrhosis accounts for approximately 80–85% of ascites cases in developed countries, other causes include malignancy, heart failure, pancreatic disease, nephrotic syndrome, and tuberculosis. Ascites significantly impacts quality of life, increases hospitalization rates, predisposes to infections, renal dysfunction, and respiratory compromise, and serves as an important indication for liver transplantation evaluation.
Pathophysiology: The formation of ascites in cirrhosis is multifactorial and results from a complex interaction among portal hypertension, systemic vasodilation, neurohormonal activation, and renal sodium retention. Portal hypertension increases hydrostatic pressure within the splanchnic circulation, causing leakage of fluid into the peritoneal cavity. At the same time, increased production of vasodilators, particularly nitric oxide, leads to profound splanchnic vasodilation. Although total body fluid increases, the effective arterial blood volume decreases because blood pools within the dilated splanchnic circulation. The body interprets this as relative hypovolemia and activates several compensatory mechanisms:
These pathways promote:
Lymph production by the liver also increases dramatically. When hepatic lymphatic drainage capacity is exceeded, excess fluid leaks into the peritoneal cavity, resulting in ascites.
As cirrhosis progresses, persistent sodium retention and worsening portal hypertension lead to increasing ascites volume and eventual development of refractory ascites.
Clinical Presentation: Patients may initially be asymptomatic. As fluid accumulates, common symptoms include abdominal distention, progressive weight gain, early satiety, anorexia, nausea, fatigue, and reduced exercise tolerance. Large-volume ascites may produce significant discomfort and abdominal pain due to stretching of the abdominal wall. Advanced ascites frequently causes:
Physical examination findings may include abdominal distention, bulging flanks, shifting dullness, fluid wave, everted umbilicus, peripheral edema, jaundice, spider angiomas, palmar erythema, gynecomastia, muscle wasting, and signs of hepatic encephalopathy.
Diagnosis: The diagnosis of ascites begins with a careful history and physical examination. Ultrasound is the most sensitive imaging modality and can detect as little as 100 mL of intraperitoneal fluid. Every patient with new-onset ascites should undergo diagnostic paracentesis unless contraindicated. Ascitic fluid analysis should include:
Serum-Ascites Albumin Gradient (SAAG): The SAAG is calculated as:
SAAG = Serum Albumin − Ascitic Fluid Albumin
A SAAG ≥1.1 g/dL indicates portal hypertension and is highly suggestive of cirrhosis-related ascites. Common interpretations include:
Finding | Likely Cause |
SAAG ≥1.1 g/dL, Low Protein | Cirrhosis |
SAAG ≥1.1 g/dL, High Protein | Cardiac ascites |
SAAG <1.1 g/dL | Malignancy, TB, Pancreatic ascites |
Management of Ascites: The goals of treatment are symptom relief, prevention of complications, and improvement of quality of life.
Sodium Restriction: Dietary sodium restriction remains the cornerstone of therapy. Most guidelines recommend limiting sodium intake to approximately 2 grams (88 mmol) daily. Excessive fluid restriction is generally unnecessary unless significant hyponatremia develops.
Diuretic Therapy: Aldosterone-mediated sodium retention is a primary mechanism of ascites formation. Spironolactone is therefore the preferred initial diuretic. A common regimen is:
The 100:40 ratio helps maintain potassium balance. Doses may be gradually increased while monitoring:
Recommended weight loss:
Therapeutic Paracentesis: Large-volume paracentesis is indicated for:
Removal of several liters often provides immediate symptom relief. When more than 5 liters are removed, intravenous albumin replacement is recommended. Recommended dose:
Albumin reduces the risk of post-paracentesis circulatory dysfunction and renal failure.
Large Ascites: Complications and Management
Large or tense ascites can result in multiple serious complications, which include:
Respiratory Compromise: Massive ascites elevates the diaphragm and reduces lung expansion. Patients may develop:
Management involves therapeutic paracentesis and optimization of ascites control.
Umbilical Hernias: Increased intra-abdominal pressure predisposes patients to umbilical hernia formation. Management involves ascites control and surgical consultation when complications occur. Complications include:
Hepatic Hydrothorax: Ascitic fluid may pass through diaphragmatic defects into the pleural space, usually on the right side. Symptoms include:
Management includes:
Abdominal Wall Rupture: Massive ascites can lead to spontaneous leakage of ascitic fluid through the abdominal wall. This condition is sometimes called "Flood Syndrome." Management includes:
Refractory Ascites: Refractory ascites is ascites that cannot be mobilized or rapidly recurs despite maximal medical therapy. Management options include:
Hepatorenal Syndrome: Progressive circulatory dysfunction may lead to severe renal vasoconstriction and kidney failure. Management includes:
Spontaneous Bacterial Peritonitis (SBP): SBP is infection of ascitic fluid without an identifiable surgically treatable intra-abdominal source. It represents one of the most serious complications of cirrhotic ascites. Mortality remains substantial despite modern therapy.
Pathogenesis: SBP results from bacterial translocation from the intestine.
Common organisms include:
Advanced cirrhosis impairs:
These abnormalities facilitate bacterial migration into ascitic fluid.
Clinical Presentation of SBP: Presentation may be subtle. Symptoms include:
Some patients present only with altered mental status or unexplained kidney injury. Any hospitalized cirrhotic patient with ascites should be evaluated for SBP.
Diagnosis of SBP: Diagnostic paracentesis is mandatory. The diagnostic criterion is:
Ascitic fluid neutrophil count ≥250 cells/mm³
Positive cultures support the diagnosis but are not required. Culture-negative neutrocytic ascites (CNNA) is described as having a similar mortality rate and presentation to spontaneous bacterial peritonitis (SBP).
Complications of SBP: SBP may rapidly progress to life-threatening complications. Major complications include:
Sepsis and Septic Shock: Systemic inflammatory response can cause profound hypotension and multi-organ dysfunction.
Acute Kidney Injury: Renal dysfunction develops frequently and significantly increases mortality.
Hepatorenal Syndrome: SBP is a major precipitating factor for hepatorenal syndrome.
Hepatic Encephalopathy: Inflammation and infection frequently worsen encephalopathy.
Multi-Organ Failure: Advanced cases may develop respiratory, cardiovascular, renal, and hepatic failure.
Death: Without treatment, mortality exceeds 90%. Even with therapy, mortality remains substantial.
Management of SBP: Treatment should begin immediately once SBP is suspected. Recommended empiric treatment includes:
Therapy is adjusted based on culture results and local resistance patterns.
Albumin Therapy: Albumin significantly reduces renal failure and mortality. A commonly recommended regimen:
Albumin is particularly important in patients with:
Monitoring: Patients require close monitoring of:
Repeat paracentesis may be considered when clinical response is inadequate.
Secondary Prophylaxis: Patients surviving SBP have a high recurrence risk. Long-term prophylaxis is generally recommended. Common regimens include:
Prophylaxis is often continued until transplantation or resolution of ascites.
Liver Transplantation: The development of ascites, refractory ascites, hepatorenal syndrome, or SBP indicates advanced liver disease. All appropriate patients should be referred for liver transplantation evaluation. Liver transplantation remains the only definitive treatment for decompensated cirrhosis.
Summary
Indications for Urgent Paracentesis in Patients with Large Ascites
Urgent paracentesis may be diagnostic, therapeutic, or both. In patients with cirrhosis and large-volume ascites, delaying paracentesis when indicated can significantly increase morbidity and mortality, particularly when infection is present.
Diagnostic (Urgent) Paracentesis: Current guidelines recommend urgent diagnostic paracentesis (ideally within 6–12 hours) for any hospitalized patient with cirrhosis and ascites who develops any of the following:
Suspected Spontaneous Bacterial Peritonitis (SBP): Clinical findings may include:
SBP may be present even in the absence of abdominal symptoms.
New or Worsening Hepatic Encephalopathy: Patients presenting with:
should undergo prompt paracentesis because SBP is a common precipitating factor.
Acute Kidney Injury (AKI): New onset:
requires evaluation for SBP.
Hypotension or Shock: Particularly when no obvious cause is identified.
Unexplained Clinical Deterioration: Including:
Gastrointestinal Bleeding: Patients admitted with Hematemesis, Melena and Hematochezia have increased risk of SBP and should undergo diagnostic paracentesis.
Newly Diagnosed Ascites: All patients with first-time ascites should undergo diagnostic paracentesis.
Therapeutic (Urgent) Paracentesis: Urgent therapeutic paracentesis is indicated when large ascites causes significant symptoms or organ dysfunction.
Respiratory Compromise: Manifested by:
Large ascites elevates the diaphragm and reduces lung expansion. Paracentesis often provides rapid symptomatic improvement.
Large or Tense Ascites: Features include:
Large-volume paracentesis can provide immediate relief.
Suspected Abdominal Compartment Syndrome: Clinical findings may include:
This is a medical emergency.
Refractory Ascites: Patients with recurrent symptomatic ascites despite sodium restriction and maximum tolerated diuretics often require repeated therapeutic paracentesis.
Umbilical Hernia Complications particularly when accompanied by:
Ascites reduction may be urgently required.
Hepatic Hydrothorax with Respiratory Symptoms: When massive ascites contributes to pleural fluid accumulation and respiratory compromise.
When Should Large-Volume Paracentesis Be Performed? The procedure should generally be performed when:
If more than 5 liters are removed, albumin replacement is recommended. Common recommendation:
Important Clinical Pearls
Paracentesis Is Safe Despite Coagulopathy
Routine correction of:
is generally not required before paracentesis in cirrhotic patients.
Major bleeding complications are uncommon.
Diagnostic Paracentesis Should Not Be Delayed: Studies show that delaying diagnostic paracentesis in hospitalized patients with cirrhosis and ascites is associated with significantly increased mortality.
Every Hospitalized Cirrhotic Patient with Ascites Should Be Considered for Diagnostic Paracentesis
Even if asymptomatic, because SBP can be clinically silent.
High-Yield Clinical Indications for Immediate Paracentesis
Clinical Scenario | Diagnostic | Therapeutic |
New-onset ascites | Yes | Sometimes |
Fever | Yes | No |
Abdominal pain/tenderness | Yes | Sometimes |
Suspected SBP | Yes | No |
Hepatic encephalopathy | Yes | No |
Acute kidney injury | Yes | No |
Hypotension/shock | Yes | No |
GI bleeding | Yes | No |
Respiratory compromise | Often | Yes |
Tense ascites | Often | Yes |
Abdominal compartment syndrome | Yes | Yes |
Refractory ascites | Sometimes | Yes |
Summary:
The most important indications for urgent paracentesis in cirrhotic patients with large ascites are:
Failure to perform timely diagnostic paracentesis in these situations is associated with increased mortality and worse clinical outcomes.
______________________________________________________________________________
Clinical Scenario:
In a patient with cirrhosis and ascites, right-sided abdominal pain that worsens with deep inspiration (pleuritic abdominal pain) is a clinically important symptom and should not be dismissed as simply "pain from ascites." Several potentially serious conditions should be considered.
1. Spontaneous Bacterial Peritonitis (SBP) Must Be Excluded First
In a cirrhotic patient with ascites, new abdominal pain should always raise concern for SBP.
Patients with SBP may present with:
Importantly, many patients with SBP have no fever and only mild abdominal tenderness.
Clinical Significance: SBP carries a mortality of approximately 20–30% even with treatment and much higher mortality if diagnosis is delayed.
Recommended Action: Urgent diagnostic paracentesis should generally be performed.
2. Stretching of the Hepatic Capsule: Large-volume ascites can increase pressure around the liver and stretch the liver capsule. The liver capsule is richly innervated and may cause:
This tends to be dull, constant, non-severe and is usually not associated with fever or leukocytosis.
3. Hepatic Hydrothorax: Ascitic fluid may migrate through diaphragmatic defects into the pleural space. Patients often complaints of:
A chest x-ray may reveal right-sided pleural effusion.
Clinical Significance: Hepatic hydrothorax usually indicates advanced portal hypertension.
4. Diaphragmatic Irritation from Massive Ascites: Large-volume ascites can elevate and irritate the diaphragm. This may produce:
This is particularly common in tense ascites.
5. Acute Cholecystitis: Cirrhotic patients can still develop routine surgical diseases.Symptoms include:
Ultrasound evaluation may be necessary.
6. Portal Vein Thrombosis: Portal vein thrombosis occurs more commonly in cirrhotic patients. Symptoms may include:
Diagnosis requires Doppler ultrasound or CT imaging.
7. Hepatocellular Carcinoma (HCC): Large tumors near the liver capsule may cause:
Pain is often gradual and progressive.
8. Budd-Chiari Syndrome: Although uncommon, hepatic vein thrombosis may present with:
This diagnosis is usually established by Doppler ultrasound.
9. Subphrenic Infection or Abscess: Particularly if recent surgery or instrumentation occurred. Symptoms include:
What Does "Pain Worse with Deep Breathing" Suggest? Pain that increases during inspiration often suggests involvement of:
In cirrhotic patients with ascites, the most common causes are:
However, SBP should always be excluded first because it is the most dangerous and treatable cause.
Practical Hospitalist Approach: For a patient with cirrhosis and ascites complaining of right-sided abdominal pain that worsens with deep inspiration:
Initial Evaluation
Strongly Consider Immediate Diagnostic Paracentesis If
Even if fever is absent, new abdominal pain in a cirrhotic patient with ascites is generally considered an indication for diagnostic paracentesis.
Clinical Pearl
Among hospitalized cirrhotic patients with ascites, new abdominal pain—especially pain associated with deep inspiration, abdominal tenderness, worsening ascites, or declining clinical status—should be considered SBP until proven otherwise. Diagnostic paracentesis is usually the first and most important test because delayed diagnosis can substantially increase mortality.
References
Angeli P, Bernardi M, Villanueva C, et al. (2018). EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology, 69(2), 406–460.
Arroyo V, Gines P, Gerbes AL, et al. (1996). Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology, 23(1), 164–176.
Biggins SW, Angeli P, Garcia-Tsao G, et al. (2021). Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome. Hepatology, 74(2), 1014–1048.
European Association for the Study of the Liver (EASL). (2018). Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatology, 69(2), 406–460.
Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. (2007). Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology, 46(3), 922–938.
Ginès P, Quintero E, Arroyo V, et al. (1987). Compensated cirrhosis: natural history and prognostic factors. Hepatology, 7(1), 122–128.
Moore KP, Wong F, Gines P, et al. (2003). The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology, 38(1), 258–266.
Orman ES, Hayashi PH, Bataller R, Barritt AS. (2014). Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clinical Gastroenterology and Hepatology, 12(3), 496–503.
Runyon BA. (2009). Management of adult patients with ascites due to cirrhosis: an update. Hepatology, 49(6), 2087–2107.
Runyon BA. (2013). Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline. Hepatology, 57(4), 1651–1653.
Tocia C, Alqahtani SA, et al. (2020). Timing of paracentesis and outcomes in hospitalized patients with cirrhosis and ascites. World Journal of Gastroenterology, 26, 727–739.
Wong F, Pantea L, Sniderman K. (2004). Midodrine, octreotide, albumin, and TIPS in the management of hepatorenal syndrome. Gut, 53(5), 739–743.
_____________________________________________________________________________